SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001082554-20-000010
Filing Date
2020-07-29
Accepted
2020-07-29 06:17:44
Documents
75
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q uthr10q06302020.htm   iXBRL 10-Q 2303967
2 EXHIBIT 10.1 uthrex10106302020.htm EX-10.1 113327
3 EXHIBIT 10.2 uthrex10206302020.htm EX-10.2 13828
4 EXHIBIT 31.1 uthrex31106302020.htm EX-31.1 16730
5 EXHIBIT 31.2 uthrex31206302020.htm EX-31.2 16730
6 EXHIBIT 32.1 uthrex32106302020.htm EX-32.1 9314
7 EXHIBIT 32.2 uthrex32206302020.htm EX-32.2 9317
  Complete submission text file 0001082554-20-000010.txt   9258162

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT uthr-20200630.xsd EX-101.SCH 52937
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT uthr-20200630_cal.xml EX-101.CAL 76501
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT uthr-20200630_def.xml EX-101.DEF 301668
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT uthr-20200630_lab.xml EX-101.LAB 740180
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT uthr-20200630_pre.xml EX-101.PRE 436100
13 EXTRACTED XBRL INSTANCE DOCUMENT uthr10q06302020_htm.xml XML 1747944
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 201055646
SIC: 2834 Pharmaceutical Preparations